(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
----------
AIM - WINNERS
----------
N4 Pharma PLC, up 29% at 1.93 pence, 12-month range 1.40-3.80p. Company's further patent application relating to Nuvec is granted in US. The granted patent is for the composition of matter of the nanoparticle itself and will sit alongside the first US patent grant, announced in January, which concerned how the nanoparticle is made using a broad description of the manufacturing process used by the company. N4 is a specialist pharmaceutical company. Nuvec is a delivery system for cancer treatments and vaccines. The company also announces that Chair John Chiplin is retiring. Non-Executive Director Chris Britten will take over the role of chair from August 1.
----------
Aferian PLC, up 26% at 12.63 pence, 12-month range 9.00-138.00p. The business-to-business video streaming solutions company completes a placing announced on Monday. A total of 26.0 million shares were placed at 12 pence per share, raising USD4.0 million. The placing price represented a 20% discount to the firm's closing price on Monday. Notes some directors and a member of the senior management team agreed to subscribe for 2.0 million shares at the same placing price.
----------
AIM - LOSERS
----------
WANdisco PLC, down 96% at 50.15 pence, 12-month range 49.00-1,429.20p. The company returns to trading following its five-month suspension. WANdisco shares had been suspended from trading in London since March, after uncovering signs of possible "fraudulent irregularities" on its books, days after announcing it was exploring a potential US listing. In July, WANdisco reported its 2022 results, prompting the suspension on its shares to be lifted. The data activation platform also confirms it has completed its USD30 million equity fundraise, announced earlier in July.
----------
Brighton Pier Group PLC, down 26% at 41.96 pence, 12-month range 35.00-89.90p. The entertainment business that owns and trades the Brighton Palace Pier says that the second quarter of its financial year has "proved more difficult". Explains sales remain behind the year prior, reflecting a "widespread decline" in disposable incomes and consumer confidence in the UK. Total sales for the six months ending June 25 are expected to be around GBP16.2 million. Adds that ongoing inflationary pressures, in particular in relation to food, beverage and staff costs, have negatively hit its operating margin. This, combined with lower sales, leads the firm to expect earnings after tax below market expectations for the half-year. Brighton Pier notes that July and August is its busiest period but says trading in July has been negatively impacted by poor weather, train strikes and a fire at a hotel opposite the entrance of the pier.
----------
By Heather Rydings, Alliance News senior economics reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
N4 Pharma Plc (N4P)
Aferian (AFRN)
Brighton Pier (PIER)